{
    "Trade/Device Name(s)": [
        "D3 DFA Varicella-zoster Virus Identification Kit"
    ],
    "Submitter Information": "Diagnostic Hybrids, Inc.",
    "510(k) Number": "K070206",
    "Predicate Device Reference 510(k) Number(s)": [
        "K951799",
        "K990141"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GQX"
    ],
    "Summary Letter Date": "August 30, 2007",
    "Summary Letter Received Date": "July 31, 2007",
    "Submission Date": "July 27, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.3900"
    ],
    "Regulation Name(s)": [
        "Varicella-zoster virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Varicella-zoster virus (VZV) antigens"
    ],
    "Specimen Type(s)": [
        "Cell culture derived from patient specimens"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope with FITC filter set"
    ],
    "Method(s)/Technology(ies)": [
        "Direct fluorescent antibody (DFA)",
        "Immunofluorescence with fluoresceinated monoclonal antibodies"
    ],
    "Methodologies": [
        "Immunofluorescence"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Control",
        "Slide"
    ],
    "Document Summary": "FDA 510(k) summary for D3 DFA Varicella-zoster Virus Identification Kit for qualitative detection of VZV in cell cultures using immunofluorescence.",
    "Indications for Use Summary": "Qualitative detection of varicella-zoster virus (VZV) in cell cultures by immunofluorescence using fluoresceinated monoclonal antibodies; not for direct patient specimen testing.",
    "fda_folder": "Microbiology"
}